Conmed Corp CNMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CNMD is a good fit for your portfolio.
News
-
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
-
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15
-
CONMED Corporation Announces Third Quarter 2023 Financial Results
-
CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023
-
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
Trading Information
- Previous Close Price
- $107.26
- Day Range
- $106.72–108.98
- 52-Week Range
- $83.05–138.40
- Bid/Ask
- $108.91 / $109.57
- Market Cap
- $3.34 Bil
- Volume/Avg
- 30,068 / 360,943
Key Statistics
- Price/Earnings (Normalized)
- 38.16
- Price/Sales
- 2.87
- Dividend Yield
- 0.75%
- Dividend Yield (Forward)
- 0.75%
- Total Yield
- 0.75%
Company Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 4,100
- Website
- https://www.conmed.com
Valuation
|
Metric
|
CNMD
|
|---|---|
Price/Earnings (Normalized) | 38.16 |
Price/Book Value | 4.14 |
Price/Sales | 2.87 |
Price/Cash Flow | 27.11 |
Price/Earnings
CNMD
Financial Strength
|
Metric
|
CNMD
|
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.66 |
Interest Coverage | 1.75 |
Quick Ratio
CNMD
Profitability
|
Metric
|
CNMD
|
|---|---|
Return on Assets (Normalized) | 3.81% |
Return on Equity (Normalized) | 11.62% |
Return on Invested Capital (Normalized) | 6.63% |
Return on Assets
CNMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Dzjnlt | $181.1 Bil | |
SYK
| Stryker Corp | Mdg | $112.6 Bil | |
MDT
| Medtronic PLC | Nmmgr | $105.4 Bil | |
BSX
| Boston Scientific Corp | Clrlt | $81.9 Bil | |
DXCM
| DexCom Inc | Yzg | $44.1 Bil | |
EW
| Edwards Lifesciences Corp | Qntmzgb | $41.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Gpnl | $24.3 Bil | |
PHG
| Koninklijke Philips NV ADR | Kbctzb | $18.9 Bil | |
ALGN
| Align Technology Inc | Rmrzklb | $16.4 Bil | |
PODD
| Insulet Corp | Jjhnj | $13.2 Bil |